Nelson Moss, MD
Neurosurgeon
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Primary Brain Tumors
- Metastatic Brain Tumors
- Low-Grade Glioma
Learn More About the Multidisciplinary Brain Metastasis Clinic at MSK
Video DetailsAbout Me
- Co-Director, Multidisciplinary Brain Metastasis Program
I am a neurosurgeon who specializes in safely and effectively treating people with primary brain tumors and metastatic brain tumors. I am passionate about providing expert, personalized care using the most innovative and minimally-invasive surgical and nonsurgical options, and have dedicated my career to the advancement of this field.
Read more
I have specialty training in neurosurgical oncology from two leading cancer centers in the United States. These experiences gave me expertise in and a unique perspective on the most advanced techniques and newest treatments available to treat brain tumors. The portfolio of approaches I use during surgery include brain mapping while my patients are either awake or asleep, MR imaging, stereotactic navigation, brachytherapy, neuroendoscopy, and laser interstitial thermal therapy. I also offer stereotactic radiosurgery and other forms of non-invasive radiosurgery.
It is a very exciting time to care for people with brain tumors. New technologies and developments in treatments and techniques, such as advances in genetic sequencing, targeted therapy, and immunotherapy are revolutionizing cancer care. I have a research background in molecular biology and have long been devoted to understanding the genetic and epigenetic causes of tumor growth and metastasis. I am optimistic that our research will allow us to better treat and control many types of brain tumors.
I am also a part of MSK’s Brain Metastasis Center. This group provides exceptional team-oriented care to people with cancer that has spread to the brain. With our group’s vast and growing set of offerings for treating brain tumors surgically and with precise radiation and focused and investigational medications, our Center is uniquely suited to finding the best treatment for each patient. It is a privilege to offer my patients access to promising clinical trials and research approaches that may not be available elsewhere.
Neurosurgery is understandably foreign to many people. My goal is to ensure that my patients and their families are well informed about their disease and its treatment. After meeting with me, I strive for my patients to have a full understanding of their options, to have an accurate idea of what each treatment involves, and to be confident about their care plan. I hope they can see the compassion, teamwork, and unwavering focus on curing each person we care for that is essential to everyone at MSK.
When I am not working, I love spending time with my family, running, swimming, and traveling.
A neurosurgeon is a doctor with special training in surgery on the central nervous system (brain, spinal cord, and nerves).
My Specialties
- Primary Brain Tumors
- Metastatic Brain Tumors
- Low-Grade Glioma
- Acoustic Neuroma (Vestibular Schwannoma)
- Meningioma and Skull Base/Craniofacial Surgery
Education
- MD, Harvard Medical School
Residencies
- Neurosurgery – NewYork–Presbyterian/Weill Cornell Medical Center/Memorial Sloan Kettering Cancer Center
Awards and Honors
- Distinguished House Staff Award, NewYork-Presbyterian/Weill Cornell Medical Center (2017)
- Charlie Kunz Scholar Award (2016)
- First Place Awardee, New York Society for Neurosurgery (2015)
- Chordoma Foundation Research Support (2014-5 and 2015-6)
- Neurosurgery Research and Education Foundation (AANS/CNS) Fellowship Award (2014-2015)
- Intel Science Talent Search National Finalist (2001)
Fellowships
- Neurosurgical Oncology – MD Anderson Cancer Center
Board Certifications
- American Board of Neurological Surgery
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Moss sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Moss
- A Phase II Study of Cs-131 Brachytherapy for People with Brain Metastases that Have Recurred
- A Study of Trastuzumab Deruxtecan for People with Brain Cancer
- Clinical Trials Co-Investigated by Dr. Moss
- A Phase I/II Study of Olaparib and Stereotactic Radiosurgery Followed by Durvalumab and Chemotherapy in People with Breast Cancer That Has Spread to the Brain
- A Phase III Study of Post-Surgical Stereotactic Radiotherapy versus Gamma Tiles to Treat Newly Diagnosed Brain Metastases
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Moss’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Nelson Moss discloses the following relationships and financial interests:
-
AstraZeneca
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].